Canlyniadau Chwilio am Awdur :: Library Catalog

1

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
2

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
3

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
4

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
5

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
6

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
7

Supplementary Table S1 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
8

Supplementary Table S4 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
9

Supplementary Table S9 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
10

Supplementary Table S8 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
11

Supplementary Table S5 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
12

Supplementary Table S7 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
13

Supplementary Table S3 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
14

Supplementary Table S6 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:
15

Supplementary Table S2 from In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Cyhoeddwyd 2025
Awduron Eraill:

Ychwanegu at ffefrynnau

Wedi'i Gadw mewn:

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness gan Alex C.H. Liu (14961921)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target gan Ana Vujovic (15207479)

Offerynnau Chwilio: